Axsome Therapeutics, Inc. (AXSM)
NASDAQ: AXSM · Real-Time Price · USD
116.45
-2.08 (-1.75%)
Mar 31, 2025, 10:11 AM EDT - Market open
Axsome Therapeutics Market Cap
Axsome Therapeutics has a market cap or net worth of $5.68 billion as of March 31, 2025. Its market cap has increased by 71.49% in one year.
Market Cap
5.68B
Enterprise Value
5.66B
1-Year Change
71.49%
Ranking
Category
Stock Price
$116.45
Market Cap Chart
Since November 19, 2015, Axsome Therapeutics's market cap has increased from $154.90M to $5.68B, an increase of 3,566.06%. That is a compound annual growth rate of 46.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 5.78B | 40.97% |
| Dec 31, 2024 | 4.10B | 8.87% |
| Dec 29, 2023 | 3.77B | 12.44% |
| Dec 30, 2022 | 3.35B | 135.22% |
| Dec 31, 2021 | 1.42B | -53.19% |
| Dec 31, 2020 | 3.04B | -14.70% |
| Dec 31, 2019 | 3.57B | 4,141.14% |
| Dec 31, 2018 | 84.10M | -36.58% |
| Dec 29, 2017 | 132.60M | 2.55% |
| Dec 30, 2016 | 129.30M | -21.30% |
| Dec 31, 2015 | 164.30M | 6.07% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |